Author Archives: Rachita Narsaria, MD

Context Partners with Research Institutions to Study Sigma1 Protein in Treatment of Fibrosis, Cancer

Context Therapeutics, a Philadelphia-based biotech, is collaborating with three leading institutions for research into the Sigma1 protein and its role in diseases. The institutions are Cedars-Sinai Medical Center, Fred Hutchinson Cancer Research Institute, and Fondation Synergie Lyon Cancer. The Sigma1 protein helps regulate the immune system and create stability…